May 8, 2018


Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering ultra-long-acting oral therapies, which has never been done before. Our novel delivery system allows people to take medicines once a week, or even less often, instead of every day, while delivering drug consistently over time.


Imagine taking a week’s worth of medicine in a single pill, once a week. Four pills a month. Eventually, one pill a month. Lyndra’s revolutionary drug delivery technology delivers a weekly – or longer – dose of medicine in one capsule. This has the potential to allow virtually any existing oral therapy to be delivered as a weekly capsule. In addition, the Lyndra delivery system will deliver drug consistently, reducing the peaks and troughs of daily dosing. This game-changing technology will free people from the burden of daily pills and make it easier to manage their health conditions, improve outcomes, and live their lives.


Tackling a problem nobody has solved for decades

Lyndra’s drug delivery platform combines 20+ patented innovations to create an oral capsule with the potential to transform virtually any therapeutic into weekly or even monthly pills. What we are striving to achieve should not be confused with “extended release” oral medicines that achieve 24-hour dosing. What we are doing is something completely new. Learn more about our drug delivery platform.


While our technology can work in virtually any therapeutic area, we know improved dosing frequency holds great potential in central nervous system (CNS) disorders, where the challenges with and consequences of low adherence are particularly profound. That is why our lead asset is oral weekly risperidone (LYN-005) for people living with schizophrenia or bipolar 1 disorder. Learn more.

Latest News